Randomized, optimal dose finding, Phase II Study of triweekly Abraxane in patients with metastatic breast cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 13 Dec 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms ABROAD
- 08 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 01 May 2015 Planned End Date changed from 1 Nov 2018 to 15 Feb 2019 as reported by Hospital Medical Information Network - Japan.
- 01 May 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.